Moore Capital Management’s Guardant Health GH Stock Holding History

Moore Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22,943	Closed	-$1.14M	–	732
2022 Q1	$1.52M	Sell	22,943 -33,089	-59%	-$2.26M	0.04%	398
2021 Q4	$5.6M	Sell	56,032 -362,308	-87%	-$37.5M	0.11%	186
2021 Q3	$52.3M	Buy	418,340 +312,319	+295%	+$37.1M	0.8%	16
2021 Q2	$13.2M	Buy	106,021 +15,652	+17%	+$2.11M	0.19%	107
2021 Q1	$13.8M	Sell	90,369 -24,689	-21%	-$3.73M	0.17%	101
2020 Q4	$14.8M	Buy	115,058 +100,058	+667%	+$11.5M	0.16%	84
2020 Q3	$1.68M	Sell	15,000 -10,000	-40%	-$915K	0.03%	273
2020 Q2	$2.03M	Buy	+25,000	New	+$2.01M	0.05%	191

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Moore Capital Management's GH Position: Q2 2022 in Review

Moore Capital Management sold out of Guardant Health (GH) in Q2 2022, closing a stake of 22,943 shares — an estimated $1.14M sold.

Moore Capital Management first reported a position in GH in Q2 2020 and held it in 8 quarters. The position peaked at $52.3M in Q3 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

Moore Capital Management reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
Moore Capital Management sold 22,943 Guardant Health shares in Q2 2022, an estimated $1.14M.
Moore Capital Management first reported a position in Guardant Health in Q2 2020 and held it in 8 quarters.
Moore Capital Management's Guardant Health position peaked at $52.3M in Q3 2021.
332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Moore Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.